GoTo Telemed Launches Comprehensive Eyelash Growth Telehealth Program

KALISPELL, Mont. - June 23, 2026 - PRLog -- GoTo Telemed, a nationwide integrated telehealth ecosystem serving over 10 million patients, today launched its Eyelash Growth Telehealth Program – a virtual care initiative providing professional evaluation, prescription management, and ongoing monitoring for individuals seeking longer, fuller eyelashes through its secure, HIPAA-compliant platform. The program is delivered by licensed healthcare providers trained in aesthetic medicine and ophthalmic safety.

Millions of Americans experience hypotrichosis—inadequate or insufficient eyelashes—resulting from genetics, aging, medical treatments such as chemotherapy, or conditions like alopecia areata and trichotillomania. While many view sparse lashes as purely cosmetic, inadequate lash growth can significantly impact self-confidence and daily comfort. Yet access to prescription lash treatments has historically required in-person dermatology or ophthalmology visits, creating barriers of time, cost, and geography.

GoTo Telemed's program removes these barriers by connecting patients with licensed providers through secure video consultations. Following a comprehensive evaluation of lash health, medical history, and eye safety, providers determine candidate suitability for FDA-approved prescription treatments. The program follows the clinically proven protocol for bimatoprost 0.03% – the only FDA-approved prescription drug for eyelash growth – which is applied nightly to the upper lash line and produces noticeable results in about 16 weeks of consistent use.

Comprehensive Virtual Lash Care Services

Service Component Description
Virtual Consultation Secure video evaluation by licensed providers to assess lash health, growth patterns, and suitability for prescription treatment
Prescription Management E‑prescribing of bimatoprost (Latisse) with personalized application guidance
Ongoing Monitoring Digital follow‑up to track progress, address side effects, and optimize results
Safety Screening Assessment of eye health, medications, and contraindications
"Eyelash hypotrichosis is not merely a cosmetic concern – for many, it affects self-confidence, daily comfort, and quality of life," said a GoTo Telemed spokesperson. "Our program extends the reach of licensed providers to individuals who otherwise might not have access to safe, effective prescription lash treatments."

The program is available immediately nationwide. Patients may self‑refer or be referred by their primary care provider. Most major insurance plans are accepted; self‑pay options are available.

Media Contact:
GoTo Telemed Media Relations
info@gototelemed.com
(660) 628-1660
https://gototelemed.com/